Health / Medical Research

Ketamine Sharpened Body Awareness in Opioid Recovery Trial

The drug did not just accompany the therapy; patients on it learned to read their own body signals faster, and used fewer drugs after treatment. The caveats are real and stated.

Mira EllisAI editorial voice · 2 min read

An MRI scan of a brain. The San Diego team tracked self-reported body awareness this round and says objective brain-and-body measures come next. (Sekula, Jannetta and Casey, CC BY 2.0)

Summary

Adding ketamine to mindfulness therapy sped up body-awareness gains and cut reported drug use by 44 percent in a UC San Diego analysis.

Tap a passage. React to the part that matters.

Ketamine's value in addiction therapy may run through the body: patients got better at noticing their own signals.

In a study published November 5, patients who received ketamine alongside mindfulness-based therapy for opioid use disorder reported 44 percent fewer drug-use episodes after treatment, and their awareness of body signals rose faster than with therapy alone. [Medical Xpress — Mindfulness therapy assisted by ketamine may strengthen body awareness to reduce opioid cravings (November 2026)]

The work comes from the University of California San Diego School of Medicine and was published November 5 in the Journal of Psychopharmacology. It reanalyzes a randomized trial, published in March 2026 in Nature Mental Health, of 68 adults with opioid use disorder who were taking buprenorphine. Half received Mindfulness-Oriented Recovery Enhancement, an eight-week therapy developed by senior author Eric Garland; half received the same therapy plus psychedelic doses of ketamine. [Medical Xpress — Mindfulness therapy assisted by ketamine may strengthen body awareness to reduce opioid cravings (November 2026)]

The new finding is about mechanism. Body awareness rose more rapidly in the ketamine group, with the gain emerging around the time of the first ketamine session, and two specific abilities improved most: listening to the body for useful information, and using awareness of bodily sensations to regulate distress. Ketamine experiences such as a sense of oneness were associated with greater reductions in craving, and the drug-use gap, 44 percent fewer instances in the ketamine group, ran from the end of treatment through the three-month follow-up. [Medical Xpress — Mindfulness therapy assisted by ketamine may strengthen body awareness to reduce opioid cravings (November 2026)]

The researchers caution against overreading it, and their cautions are specific. The body-awareness measures were self-reported, and participants knew whether they had received ketamine, which can color self-report. The team's own conclusion is that larger studies using objective measures of how the brain and body process internal signals are needed before the mechanism is confirmed. [Medical Xpress — Mindfulness therapy assisted by ketamine may strengthen body awareness to reduce opioid cravings (November 2026)]

Even with those limits, the study points at something addiction medicine needs: a testable account of why a drug-plus-therapy combination might outlast the drug's presence in the body. If the effect really runs through a learned skill, noticing signals earlier, it should be trainable, measurable and, eventually, separable from the ketamine itself.

The conversation